Drug Profile
Epoetin alfa biosimilar - Laboratorio Varifarma
Alternative Names: Epogen - Laboratorio Varifarma; Eritropoyetina alfa recombinante humanaLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Laboratorio Varifarma
- Developer Laboratorio Pablo Cassara; Laboratorio Varifarma
- Class Antianaemics; Recombinant erythropoietins
- Mechanism of Action Erythropoiesis stimulants; Erythropoietin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Anaemia
Most Recent Events
- 28 Feb 2014 Launched prior to this date for Anaemia in Argentina (IV)
- 28 Feb 2014 Launched prior to this date for Anaemia in Argentina (SC)